The Effects of Intravenous Vitamin C Administration on hs-CRP and Tumor Necrosis Factor-α Levels in Haemodialysis Patients

Authors

  • Hamid Taiebi Khosroshahi Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz
  • Yashar Talebi Department of Nephrology, Imam Reza Hospital, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz
  • Siamak Ahmadzadeh Department of Nephrology, Imam Reza Hospital, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz
  • Afshin Habibzadeh c
  • Seyyed Ehsan Mousavi Department of Nephrology, Imam Reza Hospital, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz
  • Mohammadreza Khalilzadeh Hemodialysis Center, Imam Reza Hospital, Tabriz

DOI:

https://doi.org/10.31989/ffhd.v1i8.125

Abstract

Background: It has been proved that pre-inflammatory factors increase mortality and morbidity of cardio-vascular diseases especially in hemodialysis patients. There is a great evidence for the increase of pre-inflammatory factors and vitamin C deficiency in dialysis patients. Limited data, however, are available regarding the effects of vitamin C supplementation on reduction of inflammatory markers in such patients.

Objectives: The aim of this study is to determine the changes of hs-CRP and Tumor Necrosis Factor-α (TNF-α) levels after administration of vitamin C in End Stage Renal Disease patients (ESRD) on Hemodialysis

Methods and Materials: In this clinical trial, vitamin C was administered intravenously (IV), (500 mg two times per week) for 2 months in 41 chronic hemodialysis patients and the hs-CRP and TNF-α levels of these patients were compared with a control group with no vitamin C as treatment. Besides hs-CRP and TNF-α, detailed laboratory results were evaluated before and after the study. The statistical analysis was performed using SPSS version 16 at the end of the study.

Results: The hs-CRP and TNF-α levels reduced significantly in hemodialysis patients after vitamin C supplementation (hs-CRP decreased from 7.27±3.70 to 6.60± 3.75, P< 0.001 and TNF-α decreased from 25.61±12.28 to 22.82±22.83, P= 0.006), whereas the levels of these pro-inflammatory factors increased in hemodialysis patients without vitamin C supplementation (hs-CRP increased from 7.13±3.56 to 7.73±3.83, P= 0.049 and TNF-α increased from 21.32±5.64 to 23.63±15.59, P= 0.353). Vitamin C supplementation also reduced ESR level and increased Hb level significantly but it had no influence on lipid profile.

Conclusion: According to the findings of this study, it seems that vitamin C administration can reduce hs-CRP and TNF-α level in hemodialysis patients and as a result prevent atherosclerosis. It can be concluded that administration of vitamin C supplementation is beneficial in hemodialysis patients.

Key words: hemodialysis, hs-CRP, TNF-α, Vitamin C

Downloads

Published

2011-08-30

Issue

Vol. 1 No. 8 (2011): August 2011

Section

Research Articles

License

Authors retain the copyright of their articles and grant the Functional Food Center (FFC) and its journals the right of first publication under the terms of the Creative Commons Attribution 4.0 International License.

This license permits unrestricted use, distribution, and reproduction in any medium, including commercial use, provided the original author(s) and source are properly credited. Authors may post and share their published work freely, provided that the original publication in this journal is acknowledged.

By submitting to this journal, authors confirm that their manuscripts are original, not under consideration elsewhere, and that they hold the necessary rights to grant this license. The Functional Food Center encourages open scientific exchange and allows derivative and extended works, provided attribution to the original publication is maintained.